A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons

L Bühler; M Awwad; D. H Sachs; D. K. C Cooper; M Basker; S Gojo; A Thall; J. D Down; M Sykes; D Andrews; R Sackstein; M. E WHITE-SCHARF

doi:10.1016/S0041-1345(00)01142-8

Back

A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons

Conference proceeding

Peer reviewed

A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons

L Bühler, M Awwad, D. H Sachs, D. K. C Cooper, M Basker, S Gojo, A Thall, J. D Down, M Sykes, D Andrews, …

Transplantation proceedings, Vol.32(5), pp.1100-1100

The 5th Congress of the International Xenotransplantation Association

2000

DOI: https://doi.org/10.1016/S0041-1345(00)01142-8

PMID: 10936377

Abstract

Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy

Biological and medical sciences

Bone marrow, stem cells transplantation. Graft versus host reaction

Fundamental and applied biological sciences. Psychology

Fundamental immunology

Medical sciences

Tissue, organ and graft immunology

Transfusions. Complications. Transfusion reactions. Cell and gene therapy

Metrics

5 Record Views

3 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.157 Organ Donation & Transplantation; 1.157.1939 Xenotransplantation
Web Of Science research areas: Immunology; Surgery; Transplantation
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons
Creators: L Bühler - Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
M Awwad - Biotransplant Inc, Charlestown, Massachusetts, United States
D. H Sachs - Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
D. K. C Cooper - Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
M Basker - Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
S Gojo - Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
A Thall - Biotransplant Inc, Charlestown, Massachusetts, United States
J. D Down - Biotransplant Inc, Charlestown, Massachusetts, United States
M Sykes - Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
D Andrews - Department of Pathology, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
R Sackstein - Department of Medicine, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
M. E WHITE-SCHARF - Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, United States
Publication Details: Transplantation proceedings, Vol.32(5), pp.1100-1100
Conference: The 5th Congress of the International Xenotransplantation Association
Publisher: Elsevier Science
Grant note: The Transplantation Society International Xenotransplantation Association
Academic Unit: Miller School of Medicine; UMMG Department of Pathology
Language: English
Resource Type: Conference proceeding
PMID: 10936377
Record Identifier: 991031613772702976